MRD in multiple myeloma: Moving from "minimal" to "measurable"
{{output}}
The assessment of minimal residual disease (MRD) is an important prognostic factor in hematologic malignancies, including multiple myeloma (MM). Historically defined as cancer cells undetectable by conventional morphology, MRD is now more appropriately termed ... ...
